Kiringoda Ruwan, Thurm Audrey E, Hirschtritt Matthew E, Koziol Deloris, Wesley Robert, Swedo Susan E, O'Grady Naomi P, Quezado Zenaide M N
Pediatrics and Developmental Neuroscience Branch, National Institute of Mental Health, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Arch Pediatr Adolesc Med. 2010 Jun;164(6):554-60. doi: 10.1001/archpediatrics.2010.75.
To quantify the incidence of adverse events associated with anesthesia given for research-driven imaging studies and to identify risk factors for those events in pediatric research subjects.
Retrospective cohort study.
National Institutes of Health Clinical Center.
Children and adolescents enrolled in clinical research protocols who required anesthesia for research-related imaging studies from January 2000 to September 2008.
Propofol sedation/anesthesia.
The occurrence of respiratory, cardiovascular, and all anesthesia-related adverse events that required intervention while receiving anesthetics for research-driven imaging studies and other noninvasive procedures.
We identified 607 children who received 1480 propofol anesthetic procedures for imaging studies. Seventy percent of anesthetics were given to subjects with severe diseases and significant disabilities (American Society of Anesthesiologists Physical Status [ASA] III). Anesthesia had a mean (SD) duration of 115 (55) minutes, and in 12.5% of procedures, an airway device was necessary. There were 98 notable respiratory, cardiovascular, and other events in 79 anesthetic procedures, a rate of 534 per 10 000 anesthetic procedures with 1 or more adverse events. There was no long-lasting morbidity or mortality. The ASA classification (odds ratio [OR], 2.92; 95% confidence interval [CI], 1.24-6.88), anesthetic effect duration (OR, 1.46; 95% CI, 1.25-1.70), and presence of airway abnormalities (OR, 4.41; 95% CI, 1.60-12.12) were independently associated with adverse events during anesthetic use.
In our clinical research sample of high-risk children who received sedation/anesthesia by an anesthesiologist, we observed a low incidence of adverse events and no long-term complications. Risk factors for adverse events included higher ASA classification, increasing anesthetic duration, and presence of airway abnormalities.
量化与研究驱动的影像学检查所用麻醉相关的不良事件发生率,并确定儿科研究对象中这些事件的风险因素。
回顾性队列研究。
美国国立卫生研究院临床中心。
2000年1月至2008年9月期间参加临床研究方案、因研究相关影像学检查需要麻醉的儿童和青少年。
丙泊酚镇静/麻醉。
在接受研究驱动的影像学检查及其他非侵入性操作的麻醉过程中,需要干预的呼吸、心血管及所有与麻醉相关的不良事件的发生情况。
我们确定了607名接受1480次丙泊酚麻醉进行影像学检查的儿童。70%的麻醉用于患有严重疾病和严重残疾的受试者(美国麻醉医师协会身体状况分级[ASA]Ⅲ级)。麻醉的平均(标准差)持续时间为115(55)分钟,12.5%的操作需要使用气道装置。在79例麻醉操作中有98起显著的呼吸、心血管及其他事件,每10000例有1起或更多不良事件的麻醉操作发生率为534起。未出现长期发病或死亡情况。ASA分级(比值比[OR],2.92;95%置信区间[CI],1.24 - 6.88)、麻醉作用持续时间(OR,1.46;95%CI,1.25 - 1.70)和气道异常的存在(OR,4.41;95%CI,1.60 - 12.12)与麻醉使用期间的不良事件独立相关。
在我们由麻醉医师进行镇静/麻醉的高危儿童临床研究样本中,我们观察到不良事件发生率较低且无长期并发症。不良事件的风险因素包括较高的ASA分级、麻醉持续时间增加和气道异常的存在。